12 maggio 2025|
AI
|7 months agoTrump's Drug Price Promise Sends Swiss Pharma Stocks Tumbling
Swiss pharmaceutical companies face market uncertainty as US President Trump announces imminent executive order targeting prescription drug prices, potentially affecting Swiss pharma profits.
AI
Generated IllustrationKey Takeaways
AI
- Trump announced plans to sign 'one of the most consequential decrees' in US history regarding drug prices
- Roche and Novartis stocks fell up to 3% in Zurich trading
- Trump aims to force pharmaceutical companies to accept internationally comparable prices
By The Numbers
3%
Stock decline for Swiss pharma companies
30-80%
Promised reduction in US drug prices
6%
Stock decline for Sanofi and Novo Nordisk
They Said
"The world wonders why prescription drugs are so much more expensive in the US than in other countries around the world, even though they are produced in the same laboratory by the same company"